Literature DB >> 4332040

Use of disposable micro tissue culture plates for antiviral and interferon induction studies.

R W Sidwell, J H Huffman.   

Abstract

A reproducible test system requiring small amounts of test compound was developed for evaluating antiviral and interferon-inducing activity. In the antiviral experiments, KB cells were grown in disposable polystyrene microplates covered with a standard domestic plastic wrap. Viruses used in the system were types 1 and 2 herpes simplex virus, vaccinia virus, type 3 adenovirus, myxoma virus, pseudorabies virus, type 3 parainfluenza virus, types 1A and 13 rhinovirus, vesicular stomatitis virus, coxsackievirus B, and type 2 poliovirus. Inhibition of viral cytopathogenic effect was the primary criterion of evaluation of antiviral activity. Reduction in cell and supernatant fluid virus titers was used as a secondary means of evaluation. The microplate system was adaptable for determining prophylactic, therapeutic, and inactivating effects against viruses. Mouse L-929 cells were used for the interferon induction studies, with vesicular stomatitis virus utilized as the indicator of interferon activity. Known active compounds evaluated in this microplate system had activity similar to that seen in macro in vitro systems.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4332040      PMCID: PMC376420          DOI: 10.1128/am.22.5.797-801.1971

Source DB:  PubMed          Journal:  Appl Microbiol        ISSN: 0003-6919


  19 in total

1.  UTILIZATION OF DISPOSABLE PLASTIC PLATES, WITH A SEROLOGIC MICROTECHNIC.

Authors:  J L SEVER; A C LEY; F WOLMAN; B M CAPLAN; P W CROCKETT; H C TURNER
Journal:  Am J Clin Pathol       Date:  1964-02       Impact factor: 2.493

2.  Methods for preparing tissue culture in disposable microplates and their use in virology.

Authors:  E J Sullivan; M J Rosenbaum
Journal:  Am J Epidemiol       Date:  1967-05       Impact factor: 4.897

3.  The antiviral activity of 3,4-dihydro-1-isoquinolineacetamide hydrochloride in vitro, in ovo, and in small laboratory animals.

Authors:  E Grunberg; H N Prince
Journal:  Proc Soc Exp Biol Med       Date:  1968-11

4.  Interferon-stimulating and in vivo antiviral effects of various synthetic anionic polymers.

Authors:  T C Merigan; M S Finkelstein
Journal:  Virology       Date:  1968-07       Impact factor: 3.616

5.  A micro method for performing parainfluenza virus neutralization tests.

Authors:  N J Schmidt; E H Lennette; M F Hanahoe
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

6.  Searching for antiviral materials from microbial fermentations.

Authors:  J Ehrlich; B J Sloan; F A Miller; H E Machamer
Journal:  Ann N Y Acad Sci       Date:  1965-07-30       Impact factor: 5.691

7.  Hemagglutinin of type 4 adeno-associated satellite virus.

Authors:  M Ito; H D Mayor
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

8.  Micromethod for measuring microbial sensitivity to drugs.

Authors:  W Koch; D Kaplan
Journal:  Nature       Date:  1965-10-02       Impact factor: 49.962

9.  Induction of circulating interferon by synthetic anionic polymers of known composition.

Authors:  T C Merigan
Journal:  Nature       Date:  1967-04-22       Impact factor: 49.962

10.  In vitro studies on the antiviral activity of 1, 3-bis(2-chloroethyl)-1-nitrosourea.

Authors:  R W Sidwell; G Arnett; G J Dixon
Journal:  Appl Microbiol       Date:  1966-05
View more
  39 in total

1.  In vitro anti-coxsackievirus B(3) effect of ethyl acetate extract of Tian-hua-fen.

Authors:  Zhen-Hong Li; Bao-Ming Nie; Hong Chen; Shu-Yun Chen; Ping He; Yang Lu; Xiao-Kui Guo; Jing-Xing Liu
Journal:  World J Gastroenterol       Date:  2004-08-01       Impact factor: 5.742

2.  Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879-317A).

Authors:  R W Sidwell; J H Huffman; E W Call; R P Warren; L A Radov; R J Murray
Journal:  Antimicrob Agents Chemother       Date:  1987-07       Impact factor: 5.191

3.  Isolation of herpes simplex virus clones and drug resistant mutants in microcultures.

Authors:  R J Klein
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

4.  Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine.

Authors:  Justin G Julander; Richard A Bowen; Jagadeeshwar R Rao; Craig Day; Kristiina Shafer; Donald F Smee; John D Morrey; Chung K Chu
Journal:  Antiviral Res       Date:  2008-08-15       Impact factor: 5.970

5.  Inhibition of adenovirus multiplication by metabolic inhibitors.

Authors:  R Wigand; J Schmieder
Journal:  Arch Gesamte Virusforsch       Date:  1973

6.  In vitro antiherpesviral activity of 5-alkyl derivatives of 1-beta-D-arabinofuranosyluracil.

Authors:  H Machida; S Sakata; A Kuninaka; H Yoshino; C Nakayama; M Saneyoshi
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

7.  A 7-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties.

Authors:  David B Olsen; Anne B Eldrup; Linda Bartholomew; Balkrishen Bhat; Michele R Bosserman; Alessandra Ceccacci; Lawrence F Colwell; John F Fay; Osvaldo A Flores; Krista L Getty; Jay A Grobler; Robert L LaFemina; Eric J Markel; Giovanni Migliaccio; Marija Prhavc; Mark W Stahlhut; Joanne E Tomassini; Malcolm MacCoss; Daria J Hazuda; Steven S Carroll
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

8.  Broad-spectrum antiviral activity of 2-beta-D-ribofuranosylselenazole-4-carboxamide, a new antiviral agent.

Authors:  J J Kirsi; J A North; P A McKernan; B K Murray; P G Canonico; J W Huggins; P C Srivastava; R K Robins
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

9.  Antiviral activity of 3-deazaguanine, 3-deazaguanosine, and 3-deazaguanylic acid.

Authors:  L B Allen; J H Huffman; P Dan Cook; R B Meyer; R K Robins; R W Sidwell
Journal:  Antimicrob Agents Chemother       Date:  1977-07       Impact factor: 5.191

10.  A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo.

Authors:  Craig W Day; Ralph Baric; Sui Xiong Cai; Matt Frieman; Yohichi Kumaki; John D Morrey; Donald F Smee; Dale L Barnard
Journal:  Virology       Date:  2009-10-22       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.